Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand.
about
Developmental and behavioral consequences of prenatal methamphetamine exposure: A review of the Infant Development, Environment, and Lifestyle (IDEAL) studyThe effect of prenatal methamphetamine exposure on attention as assessed by continuous performance tests: results from the Infant Development, Environment, and Lifestyle studyPrenatal exposure to bisphenol A and phthalates and infant neurobehaviorLong-term effects of neonatal methamphetamine exposure on cognitive function in adolescent miceSubcortical and cortical structural central nervous system changes and attention processing deficits in preschool-aged children with prenatal methamphetamine and tobacco exposure.Risk of neurobehavioral disinhibition in prenatal methamphetamine-exposed young children with positive hair toxicology resultsMethamphetamine toxicity and its implications during HIV-1 infection.Structural, metabolic, and functional brain abnormalities as a result of prenatal exposure to drugs of abuse: evidence from neuroimaging.Abnormalities in parentally rated executive function in methamphetamine/polysubstance exposed children.Infant temperament and high-risk environment relate to behavior problems and language in toddlersImproving the outcomes of children affected by parental substance abuse: a review of randomized controlled trialsMethamphetamine-using parents: the relationship between parental role strain and depressive symptoms.Placenta-imprinted gene expression association of infant neurobehavior.Prenatal methamphetamine exposure and inhibitory control among young school-age childrenGlobal motion perception is independent from contrast sensitivity for coherent motion direction discrimination and visual acuity in 4.5-year-old children.Prenatal exposure to recreational drugs affects global motion perception in preschool children.White matter microstructural alterations in children with prenatal methamphetamine/polydrug exposure.Validated LC-MS-MS Method for Multiresidual Analysis of 13 Illicit Phenethylamines in Amniotic Fluid.Predictors of inadequate prenatal care in methamphetamine-using mothers in New Zealand and the United States.Prenatal methamphetamine exposure, home environment, and primary caregiver risk factors predict child behavioral problems at 5 years.Grandchild of the NBAS: the NICU network neurobehavioral scale (NNNS): a review of the research using the NNNS.Examining the relationships between prenatal methamphetamine exposure, early adversity, and child neurobehavioral disinhibitionCross-national comparison of prenatal methamphetamine exposure on infant and early child physical growth: a natural experiment.Auditory evoked arousal responses of 3-month-old infants exposed to methamphetamine in utero: a nap study.Initial feasibility and acceptability of a comprehensive intervention for methamphetamine-using pregnant women in South Africa.Prenatal methamphetamine exposure and neurodevelopmental outcomes in children from 1 to 3 years.Update on the pharmacologic management of neonatal abstinence syndrome.Amphetamines, the pregnant woman and her children: a review.Effects of prenatal methamphetamine exposure: a review of cognitive and neuroimaging studies.Neurobehavioral Effects from Developmental Methamphetamine Exposure.Mechanisms involved in the neurotoxic and cognitive effects of developmental methamphetamine exposure.Alcohol, Methamphetamine, and Marijuana Exposure Have Distinct Effects on the Human Placenta.Effects of Neonatal Methamphetamine and Stress on Brain Monoamines and Corticosterone in Preweanling Rats.Learning and memory effects of neonatal methamphetamine exposure in rats: Role of reactive oxygen species and age at assessment.Frontostriatal connectivity in children during working memory and the effects of prenatal methamphetamine, alcohol, and polydrug exposure.Prenatal methamphetamine exposure is associated with reduced subcortical volumes in neonates.Prenatal methamphetamine exposure is associated with corticostriatal white matter changes in neonates.Long-term parental methamphetamine exposure of mice influences behavior and hippocampal DNA methylation of the offspring.Neonatal abstinence syndrome: Neurobehavior at 6 weeks of age in infants with or without pharmacological treatment for withdrawal.Assessment and evaluation of the high risk neonate: the NICU Network Neurobehavioral Scale.
P2860
Q26862354-148005DE-F7DD-4E05-9EA8-02DCC393D905Q28389926-2FCB8BDF-A916-463F-A1ED-C30F6F4CBED1Q28392315-EA2CF5C6-D3F2-447C-B9F3-34F71473829EQ30467530-6848C74A-FD75-4D92-99E2-B7BCD7A5704CQ33878485-A4121E38-C45F-4D44-AFD6-0720BA4180D6Q33911856-76FE0854-7B01-4BA6-B0D4-256846CC2166Q33985461-07958370-A85E-4E6B-87CF-BBA4BC7DDD39Q34336685-65F045AE-8383-4886-A001-2E6CC3A5563DQ34754214-CEB64E68-8581-49D5-9A51-B6440331849EQ34985298-D60156D4-76FB-4DA7-B05B-4E1222592C7BQ35043770-C3F5DB13-77A1-4BE3-B378-0E8DABB40BEFQ35538181-8A8DDDC8-1B82-4BAA-BFEC-570C1976B4A1Q35851041-861248C9-9026-47FC-806A-971B0B721D0BQ36084014-F344261B-53F7-49C1-A7DA-1D090F30662FQ36103938-6529F35F-F5EB-458E-AF94-3891ED68F211Q36298159-7B9EC2B1-2689-497B-9DA9-2AFBF8409926Q36791495-1F2C4357-0CA6-4C8D-8A70-1E1F20A22074Q36948814-E9A216D5-AD5F-443D-BF7A-B32604029A16Q37029522-6BEC0418-2612-48F2-AD3F-FD565CE8E324Q37040422-0C9CB189-45C4-481F-A348-8810EE9C6C6EQ37340412-9A46FDDA-0BEC-4428-8831-3D9D2F966C86Q37347114-E4EC37BC-AE90-4A61-84FB-15B024B21F60Q37627099-EE5E777E-BE8B-4DED-82AE-1C30C24A2191Q37685842-1F9E93AD-78F5-4D6B-98A7-33DC20D7AA20Q37715477-3DC67F08-407E-41C5-BB34-C0BE9B7A247EQ37719523-ADDBEA31-0D64-44AE-830A-3CDE5A4FC8B6Q37922573-29D48296-1D40-4F70-8989-0530330C7A08Q38015058-4E8343C1-E10D-4299-966D-19E97939139BQ38174009-275CB630-8CD0-42E6-94C6-10BEB99D0927Q38621196-7A25265D-D88F-47D2-94D5-7F5144BE8512Q38864093-22EA5F72-EE8C-42F0-B1B2-E8113EA54616Q40731136-E44819B8-0BEE-46F1-A3DC-3B2825FCD99EQ41341565-57D28174-FDFC-4CEC-87F9-CED82A057E22Q46339172-00BA9182-1214-43DE-96F4-7FAFF8BD9F12Q46686529-E06B72A7-633B-43D6-9184-B50A8266F3D7Q46798876-B7C06F5E-88F1-4276-8E45-2E2B8771E653Q47417240-432F094C-2AE9-43A8-9F58-B2A91B5684B5Q47911511-C48D58F8-AA36-4BEA-91D8-9702E2FD74B9Q48351317-CE263B32-C892-480B-86E7-83ADE3B7EA4CQ48570967-7AC26A1E-566E-42E6-BF8C-D88B612A3A80
P2860
Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prenatal methamphetamine expos ...... me in the USA and New Zealand.
@ast
Prenatal methamphetamine expos ...... me in the USA and New Zealand.
@en
Prenatal methamphetamine expos ...... me in the USA and New Zealand.
@nl
type
label
Prenatal methamphetamine expos ...... me in the USA and New Zealand.
@ast
Prenatal methamphetamine expos ...... me in the USA and New Zealand.
@en
Prenatal methamphetamine expos ...... me in the USA and New Zealand.
@nl
prefLabel
Prenatal methamphetamine expos ...... me in the USA and New Zealand.
@ast
Prenatal methamphetamine expos ...... me in the USA and New Zealand.
@en
Prenatal methamphetamine expos ...... me in the USA and New Zealand.
@nl
P2093
P2860
P50
P1476
Prenatal methamphetamine expos ...... ome in the USA and New Zealand
@en
P2093
Linda L LaGasse
Lynne M Smith
Marilyn A Huestis
Rizwan Z Shah
Sheri Della Grotta
P2860
P304
P356
10.1016/J.NTT.2010.06.009
P577
2010-07-06T00:00:00Z